There are, at this moment, 187 clinical trials for the neurodegenerative disease underway, the highest ever on record, according to a new report from the Alzheimer’s Association (AA). The research was published in the association’s journal, Alzheimer’s & Dementia: Translational Research and Clinical Interventions, last week, featuring data scraped from the ClinicalTrials.gov database.

The health of your microbiome (gut bacterial flora) can affect your overall health. Past research has shown the correlation between microbiomes and diseases like Alzheimer’s and other form of dementia. Recently, clinical investigators from the University of Nevada, Las Vegas identified 10 specific types of bacteria in the gut of individuals linked with the likelihood of developing Alzheimer’s disease.

According to the World Health Organization, Alzheimer's is one of our most debilitating diseases. It effectively erases who you are, insinuating itself at first with annoyance, then anger, then fright, and finally silence. It can take 20 years to play out, exhausting caregivers, family, and friends.

More than 6 million Americans are living with Alzheimer's disease, a staggering number that's expected to double within the next 30 years.

A growing body of evidence suggests that an imbalance of the human gut microbiome is associated with the development of neurodegenerative diseases like Alzheimer’s disease (AD) via neuroinflammatory processes across the gut-brain axis. Now, researchers at the University of Las Vegas have identified 10 bacterial groups associated with Alzheimer’s disease, providing new insights into the relationship between the gut and dementia.

Specific types of gut bacteria and Alzheimer's disease are closely related.

The UNLV team’s analysis found a significant correlation between 10 specific types of gut bacteria and the likelihood of developing Alzheimer’s disease.

Heart Disease is the number one cause of death for women in the United States. And one in three Nevada women have some form of heart disease. Two women share how it affects their lives, and a doctor weighs in on what women should look out for. Plus we’re checking in on the latest going on in Nevada’s Legislative Session, including health-related bills.

The UNLV team’s investigation found a big link between ten particular types of gut bacteria and the chances of getting Alzheimer’s disease. 

Could changing your diet play a role in slowing or even preventing the development of dementia? We're one step closer to finding out, thanks to a new UNLV study that bolsters the long-suspected link between gut health and Alzheimer's disease.

Lighthouse Pharmaceuticals, a clinical-stage pharmaceutical company developing therapeutics to alter the course of dementia and other degenerative diseases, announced completion of a Pre-investigational New Drug meeting with the Food and Drug Administration related to the planned Phase 2b clinical study of LHP588 and the formation of its Clinical Advisory Board (CAB). The CAB includes six members with diverse backgrounds and expertise in dementia, Alzheimer’s disease, inflammation, neurodegenerative disorders, and drug development.

A new drug shows promising results in trials, but questions remain about whether benefits outweigh side effects.